𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days*

✍ Scribed by Thompson, Dana S.; Greco, F. Anthony; Miller, Antonius A.; Srinivas, Nuggehally R.; Igwemezie, Linus N.; Hainsworth, John D.; Schacter, Lee P.; Kaul, Sanjeev; Barbhaiya, Rashmi H.; Garrow, George C.; Hande, Kenneth R.

Publisher
Nature Publishing Group
Year
1995
Tongue
English
Weight
860 KB
Volume
57
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase II study of intravenous exatecan
A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma
✍ Francisco J. Esteva; Edgardo Rivera; Massimo Cristofanilli; Vicente Valero; Mela πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

## Abstract ## BACKGROUND The objective of the current study was to determine the antitumor activity, safety, and pharmacokinetic (PK) profile of exatecan mesylate in patients with anthracycline‐resistant and taxane‐resistant, metastatic breast carcinoma. ## METHODS All patients had clinical evi